Q32 Bio (QTTB) Assets Average (2018 - 2026)

Q32 Bio's Assets Average history runs 9 years deep, the most recent figure standing at $62.7 million for Q1 2026.

• In Q1 2026, Assets Average fell 26.81% year-over-year to $62.7 million; the TTM figure through Mar 2026 stood at $62.7 million (down 26.81% YoY), while the FY2025 annual figure was $77.1 million, up 10.56% from the prior year.
• Assets Average was $62.7 million for Q1 2026 at Q32 Bio, up from $59.8 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $297.8 million in Q2 2022 to a low of $59.8 million in Q4 2025.
• Historically, Assets Average has averaged $148.1 million across 5 years, with a median of $114.4 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Assets Average rose 20.65% in 2022, then tumbled 61.9% in 2023.
• A 5-year view of Assets Average shows it stood at $245.6 million in 2022, then sank by 61.9% to $93.6 million in 2023, then rose by 5.21% to $98.4 million in 2024, then sank by 39.27% to $59.8 million in 2025, then rose by 4.93% to $62.7 million in 2026.
• The last three Assets Average figures came in at $62.7 million (Q1 2026), $59.8 million (Q4 2025), and $62.0 million (Q3 2025), per Business Quant data.